celecoxib capsule
blenheim pharmcal, inc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [ see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [ see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [ see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [ see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [
celecoxib capsule
bryant ranch prepack - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 100 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [see clinical studies (14.5) ] celecoxib is contraindicated: - in patients with known hypersensitivity to celecoxib, aspirin, or other nsaids. - in patients who have demonstrated allergic-type react
celecoxib 200 mg- celecoxib capsule
aidarex pharmaceuticals llc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5)] celecoxib is incelecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1)] celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2)] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4)] celecoxib is indicated for the management of ap in adults [see clinical studies (14.5)] celecoxib is indicated for the treatment of pd [see clinical studies (14.5)] celecoxib is contraindicated: • in patients with known hypersensitivity to celecoxib, aspirin, or other nsaids. • in patients who have demonstrated allergic
celecoxib capsule
blenheim pharmacal, inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [ see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [ see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [ see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [ see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [ see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [
celecoxib capsule
proficient rx lp - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 100 mg - carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see warnings and precautions (5) ] celecoxib is indicated for relief of the signs and symptoms of oa [see clinical studies (14.1) ] celecoxib is indicated for relief of the signs and symptoms of ra [see clinical studies (14.2) ] celecoxib is indicated for relief of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] celecoxib is indicated for the relief of signs and symptoms of as [see clinical studies (14.4) ] celecoxib is indicated for the management of ap in adults [see clinical studies (14.5) ] celecoxib is indicated for the treatment of pd [see clinical studies (14.5) ] celecoxib is contraindicated: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. teratogenic effects : celecoxib at oral doses ≥150 mg/kg
celecoxib- celecoxib capsule
preferred pharmaceuticals inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1)] for the management of the signs and symptoms of ra [see clinical studies (14.2)] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] for the management of the signs and symptoms of as [see clinical studies (14.4)] for the management of acute pain in adults [see clinical studies (14.5)] for the management of primary dysmenorrhea [see clinical studies (14.5)] celecoxib is contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. risk summary use of nsaids, including celecoxib, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celecoxib, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of celecoxib in pregnant women. data from observa
celecoxib- celecoxib capsule
nucare pharmaceuticals, inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 100 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [ see clinical studies (14.1) ] for the management of the signs and symptoms of ra [ see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [ see clinical studies (14.3) ] for the management of the signs and symptoms of as [ see clinical studies (14.4) ] for the management of acute pain in adults [ see clinical studies (14.5) ] for the management of primary dysmenorrhea [ see clinical studies (14.5) ] celecoxib capsules are contraindicated in the following patients : - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9) ]. - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids, have been reported in such patients [ see warnings and precautions
celecoxib capsule
aphena pharma solutions - tennessee, llc - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 200 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1)] . for the management of the signs and symptoms of ra [see clinical studies (14.2)] . for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] . for the management of the signs and symptoms of as [see clinical studies (14.4)] . for the management of acute pain in adults [see clinical studies (14.5)] . for the management of primary dysmenorrhea [see clinical studies (14.5)] . celecoxib capsules are contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. use of nsaids, including celecoxib capsules, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celecoxib capsules, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of celecoxib capsules i
celecoxib capsule
golden state medical supply, inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 50 mg - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1)]. for the management of the signs and symptoms of ra [see clinical studies (14.2)]. for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)]. for the management of the signs and symptoms of as [see clinical studies (14.4)]. for the management of acute pain in adults [see clinical studies (14.5)]. for the management of primary dysmenorrhea [see clinical studies (14.5)]. celecoxib capsules are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7,
celecoxib capsule
torrent pharmaceuticals limited - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib 50 mg - celecoxib is indicated for the management of the signs and symptoms of oa [see clinical studies (14.1)] . for the management of the signs and symptoms of ra [see clinical studies (14.2)] . for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3)] . for the management of the signs and symptoms of as [see clinical studies (14.4)] . for the management of acute pain in adults [see clinical studies (14.5)] . for the management of primary dysmenorrhea [see clinical studies (14.5)] . celecoxib is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to celecoxib, any components of the drug product [see warnings and precautions (5.7, 5.9)] . - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids, have been reported in such patients [see warnings and precautions (5.7, 5.8)] . -